Dr. Alissa Rachel Kahn
M.D. | Pediatric Hematology-Oncology | Female
Dr. Alissa Rachel Kahn, M.D. is a Paterson, New Jersey based Pediatric doctor with medical specialization in
Pediatric Hematology-Oncology.
Current practice location of Dr. Alissa Rachel Kahn is
703 Main St, Paterson, New Jersey - 07503-2621. She can be contacted on phone at
646-302-6298.
Dr. Alissa Rachel Kahn is a sole proprietor of her business.
NPI number (Unique professional ID) for Dr. Alissa Rachel Kahn is
1598924011 which was assigned by NPPES on 09 Jun, 2008 and it was last updated on 07 Apr, 2014.
Dr. Alissa Rachel Kahn license number is
25MA09399800 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in New Jersey.
Dr. Alissa Rachel Kahn is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Alissa Rachel Kahn basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization : | Pediatrics Pediatric Hematology-Oncology |
---|
Provider Name : | Dr. Alissa Rachel Kahn |
---|
Credential : | M.D. |
---|
Gender : | Female |
---|
Business Address:
Dr. Alissa Rachel Kahn address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address : | 703 Main St Paterson, NJ, 07503-2621 United States |
---|
Phone Number : | 646-302-6298 |
---|
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : | 1598924011 |
---|
NPI Entity Type : | Individual |
---|
First Enrolment Date : | 09 Jun, 2008 |
---|
Last Updated On : | 07 Apr, 2014 |
---|
Medicare Participation:
Dr. Alissa Rachel Kahn participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID : | 2860619269 |
---|
Medicare Enrollment ID : | I20140808000145 |
---|
Primary Specialty : | Hematology/oncology |
---|
Medical School : | Other |
---|
Graduation Year : | 2006 |
---|
Accepts Medicare? | May accept. Dr. Alissa Rachel Kahn may accepts medicare insurance. |
---|
Group Practice Association:
Dr. Alissa Rachel Kahn is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Alissa Rachel Kahn is associated with along with the number of members in that group. She may also accept medicare indirectly via these group practices.
Organisation Name : | Group Practice ID | No. of Members | Practice Address | Group Accepts Medicare |
---|
St Josephs Medical Group Pc | 8628470325 | 205 | 703 Main St Paterson, NJ - 075032621 Ph: 9737546331 | May accept |
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Alissa Rachel Kahn are as mentioned. Primary taxonomy code for Dr. Alissa Rachel Kahn, M.D. is
2080P0207X (Pediatrics Pediatric Hematology-Oncology).
Taxonomy Code | Speciality | Primary | License No. | State |
---|
2080P0207X | Pediatrics Pediatric Hematology-Oncology | Yes | 25MA09399800 | NJ |
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address : | 703 Main St Paterson, NJ, 07503-2621 United States |
---|
Phone Number : | 646-302-6298 |
---|
Business Location:
Patients can refer following map for directions to
Dr. Alissa Rachel Kahn practice address. Don't forget to take prior appointment before visiting.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.